Author

N. Elarouci

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:protein folding & dynamics· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:chicken / avian· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. DE REYNIES· 2 shared A. Der Vartanian· 1 shared A. Dereynies· 1 shared A. Mauviel· 1 shared B. Bournet· 1 shared C. Canivet· 1 shared C. Gilbert· 1 shared C. Vanbrugghe· 1 shared

Activity by Year

2019-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. DE REYNIES

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The PAXFOXO1s trigger fast trans-differentiation of chick embryonic neural cells into alveolar rhabdomyosarcoma with tissue invasive properties limited by S phase entry inhibition

G. GONZALEZ CURTO, A. Der Vartanian, Y. FRARMA, L. Manceau, L. Baldi, S. Prisco, N. ELAROUCI, F. Causeret, M. RIGOLET, F. AURADE, A. DE REYNIES, V. CONTREMOULINS, F. RELAIX, O. FAKLARIS, J. BRISCOE, , V. RIBES

This study shows PAXFOXO1 fusion proteins drive neural cells to become ARMS-like cells but are limited by G1 cell cycle arrest, which can be overcome by CYCLIN D1 or MYCN.

bioRxiv · May 18, 2020 · PreprintCancer Biology

Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer

R. Nicolle, Y. Blum, P. Duconseil, C. Vanbrugghe, N. Brandone, F. Poizat, J. Roques, M. Bigonnet, O. Gayet, M. Rubis, N. Elarouci, L. Armenoult, M. Ayadi, A. Dereynies, M. Giovannini, , N. J. Dusetti

This paper develops a transcriptomic gradient (PAMG) to predict pancreatic cancer aggressiveness and treatment response using patient-derived xenografts and clinical data.

bioRxiv · Mar 25, 2020Cancer Biology

Large-scale pan-cancer analysis reveals broad prognostic association between TGF-β ligands, not Hedgehog, and GLI1/2 expression in tumors

A. de Reynies, D. Javelaud, N. Elarouci, V. Marsaud, C. Gilbert, A. Mauviel

The paper analyzes GLI1/2 expression across multiple cancers and finds that TGF-β ligands, not Hedgehog, are prognostically associated with GLI1/2 expression.

bioRxiv · Aug 8, 2019Cancer Biology